FDA rehires staff to its medical devices division
FDA rehires staff to its medical devices division after mass layoffs
The Trump administration is reinstating some employees in the Food and Drug Administration's medical devices division after dozens were laid off as part of a government-wide cost-cutting initiative led by billionaire Elon Musk and his Department of Government Efficiency,
The U.S. Food and Drug Administration said on Friday it issued new labeling changes for testosterone products based on ...
Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a ...
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...
The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...
The Food and Drug Administration on Friday said the shortage ... In a statement, the FDA said it confirmed Novo Nordisk's "stated product availability and manufacturing capacity" of these ...
A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutide, the active ingredient in Ozempic, from its drug ...
The top official in charge of food safety and nutrition at the Food and Drug ... the Trump administration's Department of Government Efficiency, or DOGE, task force. Firings at the FDA ...
FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...
Experts say that for decades, a legal loophole has allowed companies to include chemical additives that could be potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback